Search

  • HOME
  • Search
Case Reports
11592
Two Cases of Atypical Allergic Conjunctivitis Caused by Topical Administration of Brimonidine
Seon Ha Bae, Kyoung Woo Kim, Yeoun Sook Chun
J Korean Ophthalmol Soc. 2020;61(10):1216-1220.   Published online October 15, 2020
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
Original Articles
11568
Clinical Characteristics of Allergy to a Brinzolamide 1.0%/Brimonidine 0.2% Fixed Combination in Korean Glaucoma Patients
In Ki Park, Seon Ha Bae, Kyoung Woo Kim, Yeoun Sook Chun
J Korean Ophthalmol Soc. 2020;61(9):1065-1071.   Published online September 15, 2020
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
Case Reports
10143
Brimonidine-induced Atypical Conjunctivitis with Chronic Granulomatous Anterior Uveitis
In Ki Park, Yeoun Sook Chun
J Korean Ophthalmol Soc. 2020;61(6):694-698.   Published online June 15, 2020
Full textFull text    PubreaderPubReader    ePubePub    CrossRef-TDMCrossref - TDM    PDFPDF    
Original Articles
The Relationship between Allergic Conjunctivitis due to Brimonidine and Systemic Allergic Disease in Glaucoma Patients.
Jongwook Han, Wungrak Choi, Won Seok Lee, Hyoung Won Bae, Chan Yun Kim, Gong Je Seong
J Korean Ophthalmol Soc. 2019;60(3):233-238.   Published online March 15, 2019
PDFPDF    
Clinical Effectiveness of a Brinzolamide 1%-Brimonidine 0.2% Fixed Combination for Normal Tension Glaucoma in South Koreans.
In Tae Kim, Jeong Hun Bae, Joon Mo Kim
J Korean Ophthalmol Soc. 2018;59(6):561-568.   Published online June 15, 2018
PDFPDF    
Comparison of Allergy Prevalence between Brimonidine/Timolol Fixed Combination and 0.15% Brimonidine in Glaucoma Patients.
Eun Jung Park, Yeoun Sook Chun
J Korean Ophthalmol Soc. 2018;59(5):451-458.   Published online May 15, 2018
PDFPDF    
The Efficacy of Brinzolamide 1%/Brimonidine 0.2% Fixed Combination in Normal Tension Glaucoma.
Hyun Uk Shin, Sang Wook Jin
J Korean Ophthalmol Soc. 2016;57(10):1619-1624.   Published online October 15, 2016
PDFPDF    
Case Reports
A Case of Herpetic Simplex Keratitis after Application of 0.015% Tafluprost Eye Drops.
Ho Gyun Park, Sangkyung Choi
J Korean Ophthalmol Soc. 2013;54(12):1950-1953.   Published online December 13, 2013
PDFPDF    
Original Articles
Changes in the Lacrimal Excretory System Depending on the Administration Mode of Brimonidine Tartrate: Spray vs. Irrigation.
Hyun Seung Yang, Dong Eun Oh
J Korean Ophthalmol Soc. 2011;52(5):511-518.   Published online May 15, 2011
PDFPDF    
The Antimydriatic Effect of Brimonidine 0.15% on the Dark-adapted Pupil in Dark Brown Irides.
Seung Soo Rho, Hong Seok Yang, Ho Min Lew, Jae Hong Ahn
J Korean Ophthalmol Soc. 2008;49(10):1649-1657.   Published online October 15, 2008
PDFPDF    
Randomized Controlled Trial
Prophylactic Effect of Brimonidine 0.15% on IOP Elevation After Intravitreal Triamcinolone Acetonide Injection.
Myung Won Lee, Sung Eun Kyung, Moo Hwan Chang
J Korean Ophthalmol Soc. 2008;49(5):743-752.   Published online May 15, 2008
PDFPDF    
Original Articles
Brimonidine 0.2% versus Apraclonidine 0.5% for Controlling Intraocular Pressure Elevation after Q-switched Nd:YAG Laser Posterior Capsulotomy.
Seong Lyong Jeon, Ju Yeon Lee, Kyung Wha Lee
J Korean Ophthalmol Soc. 2002;43(9):1670-1678.   Published online September 1, 2002
PDFPDF    
Randomized Controlled Trial
Prophylactic Use of Brimonidine or Apraclonidine for Intraocular Pressure Elevation following Laser Iridotomy.
Won Jun Suh, Soon Cheol Cha
J Korean Ophthalmol Soc. 2002;43(5):830-836.   Published online May 1, 2002
PDFPDF    
Original Articles
The Additive Effect of 0.2%Brimonidine[Alphagan]to Beta-Adrenergic Receptor Blockers in Patients with Open Angle Glaucoma.
Chang Woog Jeong, Gong Je Seong
J Korean Ophthalmol Soc. 2000;41(3):731-736.   Published online March 1, 2000
PDFPDF    
Randomized Controlled Trial
Prophylactic Use of Brimonidine for Intraocular Pressure Elevation after Nd: YAG Laser Posterior Capsulotomy.
S C Cha, S B Bae, H S Lim
J Korean Ophthalmol Soc. 1999;40(10):2866-2875.   Published online October 1, 1999
PDFPDF    

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374



ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2021 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next